Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Obstet Gynecol. 2018 Oct;132(4):1019–1025. doi: 10.1097/AOG.0000000000002855

Table 2.

Intrapartum characteristics

SGA
N = 816
AGA
N = 7,887
P
Gestational age (weeks) 39.1 ± 1.1 39.4 ± 1.2 <0.001
Gestational hypertension / preeclampsia 113 (13.9%) 755 (9.6%) < 0.001
Magnesium sulfate treatment 52 (6.4) 255 (3.2) <0.001
Labor
 Spontaneous
 Spontaneous, augmented
 Induced

74 (9.1)
237 (29.0)
505 (61.9)

659 (8.4)
2,620 (33.2)
4,608 (58.4)

0.05
Abruption 13 (1.6) 85 (1.1) 0.18
Anesthesia
 Regional only
 General (alone or following regional)
 None

772 (94.6)
6 (0.7)
38 (4.7)

7,363 (93.4)
43 (0.6)
481 (6.1)

0.20
Tracing in last hour before delivery (mins)
 30-39
 40-49
 50-60

69 (8.5)
57 (7.0)
690 (84.6)

577 (7.3)
430 (5.5)
6,880 (87.2)

0.08
Reached second stage of labor 723 (88.6) 7,289 (92.5) <0.001
Route of delivery
 Vaginal
 Cesarean

718 (88.0)
98 (12.0)

7,160 (90.8)
727 (9.2)

0.01
Cesarean indication *
 Fetal indications
 Dystocia/CPD/arrest
 Other

57 (7.0)
40 (4.9)
1 (0.1)

312 (4.0)
396 (5.0)
19 (0.2)

<0.001
ST-segment analysis (open group) 423 (51.8) 3,877 (49.2) 0.14

Data presented as N (%) or mean ± standard deviation

SGA, small for gestational age (birthweight < 10th percentile for gestational age); AGA, appropriate for gestational age (birthweight 10-90th percentile for gestational age)

*

Percentages are of all deliveries

Fetal indication was determined according to fetal electrocardiographic ST-segment analysis guidelines in the open group and according to local protocol and ACOG guidelines (reference #1) for fetal heart-rate monitoring in the masked group.